Intellectual Property India Publishes Patent Application for 'Aav Gene Therapy Approach For Treating Lgmd2b/Dysferlinopathy' Filed by Kate Therapeutics, Inc.

MUMBAI, India, March 14 -- Intellectual Property India has published a patent application (202617013257 A) filed by Kate Therapeutics, Inc., San Diego, on Feb. 6, for 'aav gene therapy approach for treating lgmd2b/dysferlinopathy.'

Inventor(s) include Tabebordbar, Mohammadsharif; Velez, Danielle; and Fielden, Mark.

The application for the patent was published on March 13, under issue no. 11/2026.

According to the abstract released by the Intellectual Property India: "This disclosure relates to compositions and methods for the treatment of dysferlinopathies."

The patent application was internationally filed on July 10, 2024, under International application No.PCT/US2024/037366.

Disclaimer: Curated by HT Syndication....